Correction: Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensationAuthorsQiang Zou (ORCID: https://orcid.org/0000-0002-0912-6895)Xueli CuiJingji Jin (ORCID: https://orcid.org/0000-0001-9432-5954)Yingying Li (ORCID: https://orcid.org/0000-0003-4737-7035)Feng Xue (ORCID: https://orcid.org/0000-0002-5060-7324)Yong Cai (ORCID: https://orcid.org/0000-0002-1924-1731)Yunxiao HeAiping WenInstitutionsNorth Sichuan Medical University (CN)Jilin University (CN)Changchun Discovery Sciences (China) (CN)Affiliated Hospital of North Sichuan Medical College (CN)Jilin International Studies University (CN)Publication DetailsJournalFrontiers in ImmunologyPublished2025-12-19DOIhttps://doi.org/10.3389/fimmu.2025.1761945Primary TopicCancer Immunotherapy and BiomarkersTypearticleField-Weighted Citation Impact0.00Explore the Global Research Space Interactive Map